0001193125-18-118591.txt : 20180518 0001193125-18-118591.hdr.sgml : 20180518 20180416163059 ACCESSION NUMBER: 0001193125-18-118591 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teva Pharmaceutical Finance Netherlands III B.V. CENTRAL INDEX KEY: 0001679183 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: PIET HEINKADE 107 CITY: AMSTERDAM STATE: P7 ZIP: 1019 GM BUSINESS PHONE: 31 (0)20-2193000 MAIL ADDRESS: STREET 1: PIET HEINKADE 107 CITY: AMSTERDAM STATE: P7 ZIP: 1019 GM FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teva Pharmaceutical Finance Netherlands IV B.V. CENTRAL INDEX KEY: 0001679174 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: PIET HEINKADE 107 CITY: AMSTERDAM STATE: P7 ZIP: 1019 GM BUSINESS PHONE: 31 (0)20-2193000 MAIL ADDRESS: STREET 1: PIET HEINKADE 107 CITY: AMSTERDAM STATE: P7 ZIP: 1019 GM FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL FINANCE NV CENTRAL INDEX KEY: 0001161052 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: C/O MEESPIERSON TRUST CURACAO NV STREET 2: JB GORSIAWEG 14 CITY: CURACAO NETHERLANDS ANTILLES STATE: P8 ZIP: 00000 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teva Pharmaceutical Finance IV, LLC CENTRAL INDEX KEY: 0001451275 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1090 HORSHAM ROAD CITY: NORTH WALES STATE: PA ZIP: 19454 BUSINESS PHONE: 215-591-3000 MAIL ADDRESS: STREET 1: 1090 HORSHAM ROAD CITY: NORTH WALES STATE: PA ZIP: 19454 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL FINANCE VI, LLC CENTRAL INDEX KEY: 0001536702 IRS NUMBER: 221734359 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1090 HORSHAM ROAD CITY: NORTH WALES STATE: PA ZIP: 19454 BUSINESS PHONE: 212-591-3000 MAIL ADDRESS: STREET 1: 1090 HORSHAM ROAD CITY: NORTH WALES STATE: PA ZIP: 19454 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL FINANCE V, LLC CENTRAL INDEX KEY: 0001536701 IRS NUMBER: 221734359 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1090 HORSHAM RD CITY: NORTH WALES STATE: PA ZIP: 19454 BUSINESS PHONE: 215-591-3000 MAIL ADDRESS: STREET 1: 1090 HORSHAM RD CITY: NORTH WALES STATE: PA ZIP: 19454 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teva Pharmaceutical Finance Netherlands II B.V. CENTRAL INDEX KEY: 0001628587 IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: PIET HEINKADE 107 CITY: AMSTERDAM STATE: P7 ZIP: 1019 GM BUSINESS PHONE: 31(0) 20-2193000 MAIL ADDRESS: STREET 1: PIET HEINKADE 107 CITY: AMSTERDAM STATE: P7 ZIP: 1019 GM FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL FINANCE V B.V. CENTRAL INDEX KEY: 0001527030 IRS NUMBER: 000000000 STATE OF INCORPORATION: P8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SCHOTTEGATWEG OOST 29D CITY: CURACAO STATE: P8 ZIP: 00000 BUSINESS PHONE: 5999-736-6066 MAIL ADDRESS: STREET 1: SCHOTTEGATWEG OOST 29D CITY: CURACAO STATE: P8 ZIP: 00000 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL FINANCE IV B.V. CENTRAL INDEX KEY: 0001527029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SCHOTTEGATWEG OOST 29D CITY: CURACAO STATE: P8 ZIP: 00000 BUSINESS PHONE: 5999-736-6066 MAIL ADDRESS: STREET 1: SCHOTTEGATWEG OOST 29D CITY: CURACAO STATE: P8 ZIP: 00000 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL FINANCE CO B.V. CENTRAL INDEX KEY: 0001347410 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SCHOTTEGATWEG OOST 29-D CITY: CURACAO STATE: P8 ZIP: 599-9-463 BUSINESS PHONE: 5999-7366066 MAIL ADDRESS: STREET 1: SCHOTTEGATWEG OOST 29-D CITY: CURACAO STATE: P8 ZIP: 599-9-463 CORRESP 1 filename1.htm Acceleration Request

Teva Pharmaceutical Industries Limited

5 Basel Street

P.O. Box 3190

Petach Tikva, 4951033 Israel

April 16, 2018

Via EDGAR Submission

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549 3628

Attention: Filing Desk    

 

Re: Teva Pharmaceutical Industries Limited
     Registration Statement on Form S-3
     SEC File No. 333- 222767

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Teva Pharmaceutical Industries Limited (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333- 222767), as amended by the Amendment No. 1 filed on February 16, 2018 and as amended by the Amendment No. 2 filed on March 28, 2018 (together, the “Registration Statement”), to 8:00 a.m. Eastern Time, on Thursday, April 19, 2018 or as soon thereafter as practicable. The Company hereby acknowledges its responsibilities under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

*    *    *    *

Securities and Exchange Commission

April 16, 2018

Page 2

 

Please contact Ross M. Leff of Kirkland & Ellis LLP, special counsel to the Company, at (212) 446-4947, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

 

Sincerely,

 

Teva Pharmaceutical Industries Limited

By:   /s/ Deborah Griffin
Name:   Deborah Griffin
Title:   Senior Vice President and Chief Accounting Officer
Teva Pharmaceutical Finance IV, LLC
By:   /s/ Deborah Griffin
Name:   Deborah Griffin
Title:   President, Chief Executive Officer and Manager
Teva Pharmaceutical Finance V, LLC
By:   /s/ Deborah Griffin
Name:   Deborah Griffin
Title:   President, Chief Executive Officer and Manager
Teva Pharmaceutical Finance VI, LLC
By:   /s/ Deborah Griffin
Name:   Deborah Griffin
Title:   President, Chief Executive Officer and Manager

Teva Pharmaceutical Finance Company B.V.

 

By: Teva Pharmaceutical Finance Netherlands III B.V., its Managing Director

 

By: Teva Pharmaceuticals Europe B.V., its Managing Director

By:   /s/ David Vrhovec
Name:   David Vrhovec
Title:   Managing Director
By:   /s/ John Nason
Name:   John Nason
Title:   Managing Director

Teva Pharmaceutical Finance IV B.V.

 

By: Teva Pharmaceutical Finance Netherlands II B.V., its Managing Director

 

By: Teva Pharmaceuticals Europe B.V., its Managing Director

By:   /s/ David Vrhovec
Name:   David Vrhovec
Title:   Managing Director
By:   /s/ John Nason
Name:   John Nason
Title:   Managing Director

Teva Pharmaceutical Finance V B.V.

 

By: Teva Pharmaceutical Finance Netherlands IV B.V., its Managing Director

 

By: Teva Pharmaceuticals Europe B.V., its Managing Director

By:   /s/ David Vrhovec
Name:   David Vrhovec
Title:   Managing Director
By:   /s/ John Nason
Name:   John Nason
Title:   Managing Director
Teva Pharmaceutical Finance N.V.
By:   /s/ Iseline Gouverneur
Name:   Iseline Gouverneur
Title:   Managing Director A
By:   /s/ Doron Herman
Name:   Doron Herman
Title:   Managing Director B

Teva Pharmaceutical Finance Netherlands II B.V.

 

By: Teva Pharmaceutical Europe B.V., its Managing Director

By:   /s/ David Vrhovec
Name:   David Vrhovec
Title:   Managing Director
By:   /s/ John Nason
Name:   John Nason
Title:   Managing Director

Teva Pharmaceutical Finance Netherlands III B.V.

 

By: Teva Pharmaceutical Europe B.V., its Managing Director

By:   /s/ David Vrhovec
Name:   David Vrhovec
Title:   Managing Director
By:   /s/ John Nason
Name:   John Nason
Title:   Managing Director

Teva Pharmaceutical Finance Netherlands IV B.V.

 

By: Teva Pharmaceutical Europe B.V., its Managing Director

By:   /s/ David Vrhovec
Name:   David Vrhovec
Title:   Managing Director
By:   /s/ John Nason
Name:   John Nason
Title:   Managing Director

 

cc: Ross M. Leff
     Kirkland & Ellis LLP